| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.00B | 68.72B | 63.30B | 54.70B | 47.69B | 41.90B |
| Gross Profit | 13.25B | 12.44B | 11.35B | 9.43B | 7.71B | 6.98B |
| EBITDA | 4.09B | 4.04B | 3.73B | 3.16B | 2.35B | 2.30B |
| Net Income | 2.44B | 2.50B | 2.39B | 2.06B | 1.63B | 1.38B |
Balance Sheet | ||||||
| Total Assets | 45.29B | 44.17B | 38.64B | 34.35B | 30.01B | 27.93B |
| Cash, Cash Equivalents and Short-Term Investments | 9.70B | 7.87B | 6.97B | 6.61B | 6.15B | 7.35B |
| Total Debt | 9.51B | 7.72B | 4.41B | 3.78B | 2.47B | 2.58B |
| Total Liabilities | 18.20B | 17.11B | 14.05B | 12.18B | 9.79B | 9.03B |
| Stockholders Equity | 26.97B | 26.93B | 24.48B | 22.18B | 20.22B | 18.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 495.24M | 800.87M | 329.26M | 151.82M | 2.02B |
| Operating Cash Flow | 0.00 | 1.19B | 1.84B | 838.38M | 536.48M | 2.35B |
| Investing Cash Flow | 0.00 | -2.89B | -1.80B | -879.51M | -592.53M | -821.74M |
| Financing Cash Flow | 0.00 | 2.49B | 167.46M | 426.39M | -1.19B | 362.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥26.47B | 14.38 | ― | 4.20% | -1.15% | -34.09% | |
77 Outperform | ¥20.72B | 6.66 | ― | 0.92% | -1.79% | -8.54% | |
75 Outperform | ¥26.27B | 8.20 | ― | 2.77% | 8.92% | 15.98% | |
75 Outperform | ¥13.59B | 6.74 | ― | 3.90% | -1.72% | 168.62% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥19.73B | 18.77 | ― | 3.19% | -8.99% | -62.26% | |
47 Neutral | ¥25.18B | -5.63 | ― | 3.33% | -3.91% | -36.53% |